Athenex (ATNX) Prices 10M Share Common Offering at $11/Sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. NVDA
2. PCG
3. AVGO
4. ALNY
5. CNS
6. EC
7. SPCX
8. APO
9. SRE
10. HDB

Go back to Athenex (ATNX) Prices 10M Share Common Offering at $11/Sh

Pre-Open Stock Movers 09/09: (TRIL) (NLS) (TSLA) Higher; (WORK) (ANTX) (LULU) Lower (more...)

September 9, 2020 9:28 AM EDT

Today's Pre-Open Stock Movers:

Trillium Therapeutics Inc. (NASDAQ: TRIL) 42.7% HIGHER; announced that it has agreed to sell 2,297,794 of its common shares at a price of $10.88 per share to Pfizer Inc. (NYSE: PFE), for gross proceeds of $25.0 million (the Transaction). The common shares were offered and sold to Pfizer Inc. in a registered direct offering conducted without an underwriter or placement agent. The offering is expected to close on or about September 10, 2020.

Slack (NYSE: WORK)... More

After-Hours Movers 09/08: (TRIL) (NVAX) (QRVO) Higher; (WORK) (ATNX) (LULU) Lower (more...)

September 8, 2020 5:58 PM EDT

Today's After-Hours Movers:

Trillium Therapeutics Inc. (NASDAQ: TRIL) 28% HIGHER; $25.0 million (the Transaction). The common shares were offered and sold to Pfizer Inc. in a registered direct offering conducted without an underwriter or placement agent. The offering is expected to close on or about September 10, 2020.

Slack (NYSE: WORK) 18% LOWER; reported Q2 EPS of $0.00, $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $215.9 million versus the consensus estimate of $209.1 million. Slack sees Q3 2021 EPS of... More

Athenex (ATNX) Announces Proposed 10M Share Public Offering of Common Stock

September 8, 2020 4:01 PM EDT

Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced that it intends to offer and sell, subject to market conditions, 10,000,000 shares of its common stock in an underwritten... More